Related Experiment Video
Updated: Jun 26, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Cytisine-based nicotinic partial agonists as novel antidepressant compounds
Yann S Mineur1, Christoph Eibl, Grace Young
1Department of Psychiatry, Yale School of Medicine, New Haven, CT 06508, USA.
The Journal of Pharmacology and Experimental Therapeutics
|January 24, 2009
Summary
Novel nicotinic partial agonists, like 3-(pyridin-3'-yl)-cytisine, demonstrate antidepressant-like effects in mice. These compounds show potential for developing new mood disorder treatments by targeting nicotinic acetylcholine receptors (nAChRs).
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Nicotine and related compounds influence mood and exhibit antidepressant properties in animal studies.
- Blockade of nicotinic acetylcholine receptors (nAChRs), particularly those with the beta2 subunit, has shown antidepressant-like effects.
- Cytisine, a known partial agonist, displays antidepressant-like properties, but the efficacy of more selective partial agonists remains unclear.
Purpose of the Study:
- To evaluate the antidepressant-like activity of cytisine derivatives, 5-bromo-cytisine (5-Br-Cyt) and 3-(pyridin-3 zez-yl)-cytisine (3-pyr-Cyt).
- To determine the nAChR subtype selectivity and efficacy of these novel compounds.
- To assess their potential for treating mood disorders.
Main Methods:
- Testing cytisine and its derivatives (5-Br-Cyt, 3-pyr-Cyt) for partial agonism at various nAChR subtypes.
- Administering compounds to C57/BL6 mice and evaluating antidepressant-like activity using the tail suspension, forced-swim, and novelty-suppressed feeding tests.
- Investigating the effect of blood-brain barrier penetration on 5-Br-Cyt's efficacy via peripheral and intraventricular administration.
Main Results:
- 3-(pyridin-3 zez-yl)-cytisine selectively acted as a low-efficacy partial agonist at alpha4/beta2(*) nAChRs with no activity at other cytisine-targeted nAChRs.
- 3-(pyridin-3 zez-yl)-cytisine demonstrated dose-dependent antidepressant-like effects in all three behavioral tests.
- 5-bromo-cytisine showed no peripheral efficacy, likely due to poor blood-brain barrier penetration, but was effective when administered intraventricularly.
Conclusions:
- Selective nicotinic partial agonists, exemplified by 3-(pyridin-3 zez-yl)-cytisine, can exhibit significant antidepressant-like activity.
- These findings suggest that targeting specific nAChR subtypes with novel partial agonists offers a promising avenue for developing new medications for mood disorders.
- The ability to cross the blood-brain barrier is crucial for the in vivo efficacy of these compounds.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...